|
VYGR Voyager Therapeutics Inc 1640266 |
| Balance Sheet |
|
Current Assets
|
$125,228,000.00 |
|
Assets
|
$197,753,000.00 |
|
Current Liabilities
|
$16,685,000.00 |
|
Liabilities
|
$43,376,000.00 |
|
Equity
|
$154,377,000.00 |
|
Shares Out
|
61273390.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-59,261,000.00 |
|
Investing Cash Flow
|
$23,492,000.00 |
| Market Analysis |
Market Cap
|
$203,427,654.80 |
|
Price
|
$3.32 |
|
BVPS
|
2.52 |
|
PB
|
1.32 |
|
EPS
|
-0.40 |
|
PS
|
16.07 |
|
FCF
|
$-59,275,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:46 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:37 |
|
| Apr |
May |
Jun |
| 2026-03-09 |
-0.46 |
|
|
2026-05-07 |
-0.47 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-0.57 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.47 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VYGR documents filed with the SEC.
VYGR Filings
Clear
